Skip to main content
. 2021 Jul 13;13(7):2389. doi: 10.3390/nu13072389

Table 1.

Baseline population characteristics.

ALL MD LFD p-Value
N = 130 n = 64 n = 66
Men (n%) 113 (86.9%) 54 (84.4%) 59 (89.4%) 0.40
Age (years) 62.2 ± 9.5 63.0 ± 6.8 61.5 ± 11.6 0.35
Height (m) 1.70 ± 0.09 1.69 ± 0.09 1.70 ± 0.08 0.77
Body Weight (Kg) 79.2 ± 12.5 77.6 ± 12.2 80.8 ± 12.6 0.18
BMI (Kg/m2) 27.47 ± 3.46 27.1 ± 3.3 27.8 ± 3.6 0.31
Waist circumference (cm) 98.0 ± 9.8 97.0 ± 9.8 99.0 ± 9.8 0.33
Smoking (n%) 0.26
former smoker 77 (59.2%) 37 (57.8%) 40 (60.6%)
current smoker 15 (11.5%) 5 (7.8%) 10 (15.2%)
non-smoker 38 (29.2%) 22 (34.4%) 16 (24.2%)
Physical activity (n%) 0.47
intense 29 (22.3%) 14 (21.9%) 15 (22.7%)
average 41 (31.5%) 18 (28.1%) 23 (34.9%)
low 60 (46.2%) 32 (50.0%) 28 (42.4%)
Total cholesterol (mg/dL) 167.6 ± 29.2 172.7 ± 29.1 162.6 ± 28.5 0.05
HDL-cholesterol (mg/dL) 50.9 ± 13.0 49.8 ± 12.5 51.9 ± 13.5 0.45
LDL-cholesterol (mg/dL) 93.8 ± 25.5 99.3 ± 26.3 88.5 ± 23.6 0.02
Triglycerides (mg/dL) 114.4 ± 57.7 117.9 ± 63.2 111.1 ± 52.0 0.93
Fasting blood glucose (mg/dL) 101.9 ± 10.4 100.1 ± 9.1 103.7 ± 11.3 0.14
SBP (mmHg) 132.4 ± 18.0 132.8 ± 16.8 131.9 ± 19.3 0.63
DBP (mmHg) 79.4 ± 10.2 79.0 ± 10.9 79.9 ± 9.5 0.63
On lipid-lowering therapy (n%) 119 (91.5%) 55 (85.9%) 64 (97.0%) 0.02
On antihypertensive therapy (n%) 119 (91.5%) 60 (93.8%) 59 (89.4%) 0.37
On antiplatelet therapy (n%) 123 (94.6%) 61 (95.3%) 62 (93.9%) 0.73
Total medicines (median [min; max]) 5 [3;9] 5 [3; 9] 5 [3; 9] 0.94
MeDAS Score 7.25 ± 1.6 7.36 ± 1.4 7.14 ± 1.8 0.47

Continuous variables are expressed as mean ± standard deviation; categorical data are presented as frequency and (percentage). MD: Mediterranean diet; LFD: low-fat diet; MeDAS score: Mediterranean Diet Adherence Screener score; SBP: systolic blood pressure; DBP: diastolic blood pressure.